Atrial natriuretic peptide (anp) as an additive to...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/22 (2006.01) A61M 1/28 (2006.01)

Patent

CA 2261681

The present invention provides a peritoneal dialysis solution that contains atrial natriuretic peptide (ANP), a derivative of ANP, an analogue of ANP, a substance that binds ANP to clearance receptors or a substance that promotes ANP synthesis, which results in an increased net ultrafiltration and increased sodium clearance experienced in peritoneal dialysis patients.

La présente invention concerne une solution de dialyse péritonéale renfermant un peptide natriurétique atrial (ANP), un dérivé d'ANP, un analogue d'ANP, une substance liant l'ANP à des récepteurs de clairance ou une substance favorisant la synthèse d'ANP, ce qui a permis d'observer chez des patients soumis à une dialyse péritonéale une ultrafiltration nette et une clairance du sodium accrues.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Atrial natriuretic peptide (anp) as an additive to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Atrial natriuretic peptide (anp) as an additive to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Atrial natriuretic peptide (anp) as an additive to... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1695986

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.